Aadi Bioscience (STU:3350) 3-Year Revenue Growth Rate : 10.40% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Aadi Bioscience 3-Year Revenue Growth Rate?

Aadi Bioscience's Revenue per Share for the three months ended in Mar. 2024 was €0.18.

During the past 12 months, Aadi Bioscience's average Revenue per Share Growth Rate was 14.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was 10.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 4 years, the highest 3-Year average Revenue per Share Growth Rate of Aadi Bioscience was 10.40% per year. The lowest was 10.40% per year. And the median was 10.40% per year.

Competitive Comparison of Aadi Bioscience's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, Aadi Bioscience's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aadi Bioscience's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aadi Bioscience's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Aadi Bioscience's 3-Year Revenue Growth Rate falls into.

Aadi Bioscience 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Aadi Bioscience (STU:3350) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Aadi Bioscience 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Aadi Bioscience's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Aadi Bioscience (STU:3350) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aadi Bioscience Inc (STU:3350) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

AADI:USA

Address

17383 Sunset Boulevard, Suite A250, Pacific Palisades, CA, USA, 90272

Website

https://www.aadibio.com

Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.

Aadi Bioscience (STU:3350) Headlines

No Headlines